KYNB
Kyntra Bio, Inc. Common StockRecent alerts on KYNB
All signals →
News
Kyntra Bio targets Q4 2026 interim readout while extending cash runway into 2028
21d ago
SEC filing
KYNB Delisted from Nasdaq Global Select Market; $50M Asset/Revenue Requirement Missed; 45-Day Plan Due May 18 2026; Potential Transfer to Nasdaq Capital Market
54d ago
News
FibroGen GAAP EPS of -$3.51 beats by $0.37, revenue of $1.27M misses by $0.4M
78d ago
SEC filing
KYNB Reports $1.3M Q4 Rev, $58.2M Net Loss, $109.4M Cash Runway to 2028, Launches Phase 3 Roxadustat Protocol Submission
78d ago
News
FibroGen Q4 2025 Earnings Preview
79d ago
News
Oil Declines As Iran Says 'Understanding' Reached In US Nuclear Negotiation
105d ago
News
Bain Capital and Goldman Sachs Lead Financing for Truelink Capital's Acquisition of SouthernCarlson from Kyocera Corporation – Company Announcement - FT.com
112d ago
Scanner
Unusual volume (3.1x average)
124d ago
Get push alerts for KYNB
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS